Zeb1 links epithelial-mesenchymal transition and cellular senescence

Development

Volumn 135, Issue 3, 2008, Pages 579-588

  Liu, Yongqing ^a   El Naggar, Shahenda ^a   Darling, Douglas S ^b   Higashi, Yujiro ^c   Dean, Douglas C ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Epithelial mesenchymal transition; Senescence; Transcription; Zeb1

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZINC FINGER E BOX BINDING HOMEOBOX TRANSCRIPTION FACTOR 1; CADHERIN; CDKN2B PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HOMEODOMAIN PROTEIN; KRUPPEL LIKE FACTOR; REPRESSOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; ZEB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; CANCER CELL; CELL CYCLE; CELL DIVISION; CELL MATURATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EMBRYO; EMBRYO CELL; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE LOSS; GENE MUTATION; MESENCHYME CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PALATE DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENESCENCE; STEM CELL; ANIMAL; BRAIN; CARTILAGE; CELL AGING; CYTOLOGY; DRUG EFFECT; EMBRYO (ANATOMY); EPITHELIUM; EYE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; MESODERM; METABOLISM; MOUSE MUTANT; MUTATION; PALATE; PRENATAL DEVELOPMENT;

MUS;

ANIMALS; BRAIN; CADHERINS; CARTILAGE; CELL AGING; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EMBRYO, MAMMALIAN; EPITHELIUM; EYE; FIBROBLASTS; GENE DOSAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MESODERM; MICE; MICE, MUTANT STRAINS; MUTATION; PALATE; REPRESSOR PROTEINS; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

EID: 41649109459     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.007047     Document Type: Article

References (48)

1. Chamberlain, E. M. and Sanders, M. M. (1999). Identification of the novel player deltaEF1 in estrogen transcriptional cascades. Mol. Cell. Biol. 19, 3600-3606.
2. Cheung, M., Chaboissier, M. C., Mynett, A., Hisrt, E., Shedl, A. and Briscoe, J. (2005). The transcriptional control of trunk neural crest induction, survival and delamination. Dev. Cell 8, 179-192.
3. Chinnadurai, G. (2002). CtBP an unconventional transcriptional corepressor in development and oncogenesis. Mol. Cell 9, 213-224.
4. Claus, R. and Lubbert, M. (2003). Epigenetic targets in hematopoietic malignancies. Oncogene 22, 6489-6496.
5. Curtis, M. A., Kam, M., Nannmark, U., Anderson, M. F., Axell, M. Z., Wikkelso, C., Holtas, S., van Roon-Mom, W. M., Bjork-Eriksson, T., Nordborg, C. et al. (2007). Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science 315, 1243-1249.
6. Darling, D. S., Stearman, R. P., Qi, Y., Qiu, M. S. and Feller, J. P. (2003). Expression of Zfhep/deltaEf1 protein in palate, neural progenitors and differentiated neurons. Gene Expr. Patterns 3, 709-717.
7. Dillner, N. B. and Sanders, M. M. (2002). The zinc finger/ homeodomain protein deltaEF1 mediates estrogen-specific induction of the ovalbumin gene. Mol. Cell. Endocrinol. 192, 85-91.
8. Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Cano, A., Beug, H. and Foisner, R. (2005). DeltaEf1 is a transcriptional repressor of e-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24, 2375-2385.
9. Genetta, T., Ruezinsky, D. and Kadesch, T. (1994). Displacement of an E box binding repressor by basic helix-loop-helix proteins, implications for B-cell specificity of the immunoglobulin heavy-chain enhancer. Mol. Cell. Biol. 14, 6153-6163.
10. Gil, J. and Peters, G. (2006). Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7, 667-677.
11. Grooteclaes, M. L. and Frisch, S. M. (2000). Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19, 3823-3828.
12. Guaita, S., Puig, I., Franci, C., Garrido, M., Domínguez, D., Battle, E., Dedhar, S., De Herreros, A. G. and Baulida, J. (2002). Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 277, 39209-39216.
13. Hay, E. D. and Zuk, A. (1995). Transformations between epithelium and mesenchyme, normal, pathological and experimentally induced. Am. J. Kidney Dis. 26, 678-690.
14. Hemavathy, K., Ashraf, S. L. and Ip, Y. T. (2005). Snail/slug family of repressors, slowly going into the fast lane of development and cancer. Gene 257, 1-12.
15. Higashi, Y., Moribe, H., Takagi, T., Sekido, R., Kawakami, K., Kikutani, H. and Kondoh, H. (1997). Impairment of T cell development in deltaEf1 mutant mice. J. Exp. Med. 185, 1467-1479.
16. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. and van Lohuizn, M. (1999). The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168.
17. Kim, S. H., Rowe, J., Fujii, H., Jones, R., Schmierer, B., Kong, B. W., Kuchler, K., Foster, D., Ish-Horowicz, D. and Peters, G. (2006). Upregulation of chicken p15INK4b at senescence and in the developing brain. J. Cell Sci. 119, 2435-2443.
18. Latres, E., Malumbres, M., Sotillo, R., Martin, J., Ortega, S., Martin-Caballero, J., Flores, J. M., Cordon-Cardo, C. and Barbacid, M. (2000). Limited overlapping roles for p15ink4b and p18ink4c cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19, 3496-3506.
19. Lazarova, D. L., Bordonaro, M. and Sartorelli, A. C. (2001). Transcriptional regulation of the vitamin D3 receptor gene by ZEB. Cell Growth Differ. 12, 319-326.
20. Lessard, J. and Sauvageau, G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260.
21. Lingbeek, M. E., Jacobs, J. J. and van Lohuizen, M. (2002). The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J. Biol. Chem. 277, 1234-1246.
22. Liu, Y., Constatino, M. E., Montoya-Durango-D., Higashi, Y., Darling, D. S. and Dean, D. C. (2007). The zinc finger transcription factor, ZFHX1A, is linked to cell proliferation by Rb/E2F1. Biochem. J. 408, 79-85.
23. Lowe, S. W. and Sherr, C. J. (2003). Tumor suppression by INK4a-Arf, progress and puzzles. Curr Opin. Genet. Dev. 13, 77-83.
24. Messing, A. and Brenner, M. (2003). GFAP, functional implications gleaned from studies of genetically engineered mice. Glia 43, 87-90.
25. Mishra, L., Derynck, R. and Mishra, B. (2005). Transforming growth factor-beta signaling in stem cells and cancer. Science 310, 68-71.
26. Molofsky, A. V., He, S., Bydon, M., Morrison, S. J. and Pardal, P. (2005). Bmi-1 promotes neural stem cell self-renewal and neural development but not growth and survival by repressing the p16INK4a and p19Arf senescence pathways. Genes Dev. 19, 1432-1437.
27. Molofsky, A. V., Slutsky, S. G., Joseph, M. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E. and Morrison, S. J. (2006). Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448-452.
28. Nishimura, G., Manabe, I., Tsushima, K., Fujiu, K., Oishi, Y., Maemura, K., Miyagishi, M., Hagashi, Y., Kondoh, H. and Nagai, R. (2006). delta EF1 regulates TGF- beta signaling in vascular smooth muscle cell differentiation. Dev. Cell 11, 93-104.
29. Ohtani, N., Zebedee, Z., Huot, T. J., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peters, G. and Hara, E. (2001). Opposing effects of ets and Id proteins on p16INK4A expression during cellular senescence. Nature 409, 1067-1070.
30. Peinado, H., Olmeda, D. and Cano, A. (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epitheiial phenotype? Nat. Rev. Cancer 7, 415-428.
31. Pena, C., Garcia, J. M., Silva, J., Garcia, V., Rodríguez, R., Alonso, I., Salas, C., de Herreros, A. G., Munoz, A. and Bonilla, F. (2005). E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer, clinicopathological correlations. Hum. Mol. Genet. 14, 3361-3370.
32. Postigo, A. A. (2003). Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway EMBO J. 22, 2443-2452.
33. Postigo, A. A. and Dean, D. C. (1999). ZEB represses transcription through interaction with the corepressor CtBP. Proc. Natl. Acad. Sci. USA 96, 6683-6688.
34. Postigo, A. A. and Dean, D. C. (2000). Differential expression and function of members of the zfh-1 family of zinc finger/homeodamain repressors. Proc. Natl. Acad. Sci. USA 97, 6391-6396.
35. Postigo, A., Depp, J. L., Taylor, J. T. and Kroll, K. L. (2003). Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 22, 2453-2462.
36. Reynisdottir, I., Polyak, K., Iavarone, A. and Massague, J. (1995). Kip/Cip and Ink4a inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9, 1831-1845.
37. Ringrose, L., Ehret, H. and Paro, R. (2004). Distinct contributions of histone H3 lysine 9 and 27 methylation to locus-specific stability of polycomb complexes. Mot. Cell 16, 641-653.
38. Sekido, R., Murai, K., Funahashi, J., Karachi, Y., Fujisawa-Sehara, A., Nabeshima, Y. and Koncloh, H. (1994). The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation. Mol. Cell. Biol. 14, 5692-5700.
39. Spoelstra, N. S., Manning, N. G., Higashi, Y., Darling, D., Singh, M., Shroyer, K. R., Broadddus, R. R., Horwitz, K. B. and Richer, J. K. (2006). The transcription factor ZEB1 is alberrantly expressed in aggressive uterine cancers. Cancer Res. 66, 3893-3902.
40. Takagi, T., Moribe, H., Koncloh, H. and Higashi, Y. (1998). deltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development 125, 21-31.
41. Thiery, J. P. (2003). Epithelia-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746.
42. Valk-Lingbeek, M. E., Bruggeman, S. W. and van Lohuizen, M. (2004). Stem cells and cancer; the polycomb connection. Cell 118, 409-418.
43. van Grunsven, L. A., Taelman, V., Michiels, C., Van cle Putte, T., Nelles, L., Wuytens, G., Verschueren, K. and Huylebroeck, D. (2006). deltaEF1 and SIP1 are differentially expressed and have overlapping activities during Xenopus embryogenesis. Dev. Dyn. 235, 1491-1500.
44. Wang, J., Scully, K., Zhu, X., Cai, L., Zhang, J., Prefontaine, G. G., Krones, A., Ohgi, K. A., Zhu, P., Garcia-Bassets, I. et al. (2007). Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446, 882-887.
45. Witta, S. E., Gemmill, R. M., Hirsch, F. R., Coldren, C. D., Hedman, K., Ravdel, L., Helfrich, B., Dziadziuszko, R., Chan, D. C., Sugita, M. et al. (2006). Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 66, 944-950.
46. Wolff, L., Garin, M. T, Koller, R., Bies, J., Liao, W., Malumbres, M., Tessarollo, L., Powell, D. and Perella, C. (2003). Hypermethylation of the ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15ink4b-deficient mice. Oncogene 22, 9265-9274.
47. Zavadil, J. and Bottinger, E. P. (2005). TGF-β and epithelial-to-mesenchymal transitions. Oncogene 24, 5764-5774.
48. Zhang, Q., Yao, H. N., Vo, N. and Goodman, R. H. (2000). Acetylation of adenovirus E1a regulates binding of the transcriptional corepressors CtBP. Proc. Natl. Acad. Sci. USA 97, 14323-14328.